Effects of Laryngeal Tube Ventilation on no Flow Time During Out of Hospital Cardiac Arrest (FLOWERS)

July 2, 2012 updated by: University Hospital, Grenoble

Reduction of no Flow Time During Out of Hospital Cardiac Arrest by Using Laryngeal Tube for Airway Management by Nurses.

International recommendations stress on the importance of no flow time reduction in cardiac arrest management. In fact, no flow time is an independent factor of morbidity and mortality.

In France, cardiac arrests are treated by first responders (including emergency nurses) before the arrival of a mobile intensive care unit. Those first responders use bag-valve-mask for ventilation and therefore practice conventional CPR (30 chest compression / 2 ventilation rhythm). Laryngeal tube is a safe and efficient device in cardiac arrest ventilation. The purpose of our study is to compare the no flow time between two strategies of out of hospital cardiac arrest management by first responders: conventional CPR with bag-valve-mask ventilation vs. compression only CPR with Laryngeal Tube ventilation.

Study Overview

Detailed Description

Multicentric, prospective, controlled, randomized study with parallel groups in single blind.

Patients will be included in chronological periods to avoid selection biais (one month with the first medical device the next month with the other one). The determination of these periods will be centralized. The emergency vehicles will be supplied sufficiently with devices. This design has been chosen in order to answer to the emergency problem.

Patients will be included and ventilated by paramedical staff (first responders) before medical staff (Mobile Intensive Care Unit) intervention. Complete detailed information will be given to the patient or to the family and consent asked.

The comparison of no flow time between the two strategies in out of hospital cardiac arrest will be the following :

A : ventilation by bag valve mask and interrupted chest compression B : ventilation by laryngeal tube and continuous chest compression

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Isere
      • Fontaine, Isere, France, 38602
        • SDIS
      • Grenoble, Isere, France, 38043
        • Samu Smur

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • preliminary treatment of cardiac arrest by fire fighters (Basic Life support)
  • more than 18 years
  • patient affiliated to the social security system or equivalent

Exclusion Criteria:

  • certain death
  • patient deprived of freedom by judicial or administrative decision
  • patient under legal protection
  • Pregnancy, parturient or breast feeding
  • facial trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ventilation by laryngeal tube
ventilation by laryngeal tube and continuous chest compression
Comparison of no flow time between two strategies in out of hospital cardiac arrest
Other Names:
  • Laryngeal Tube LTD, VBM
Sham Comparator: ventilation by bag valve mask
ventilation by bag valve mask and interrupted chest compression
Comparison of no flow time between two strategies in out of hospital cardiac arrest
Other Names:
  • Laryngeal Tube LTD, VBM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparison of no flow time between two strategies
Time Frame: arrival of paramedical staff T0

group A : ventilation by bag valve mask and interrupted chest compression group B : ventilation by laryngeal tube and continuous chest compression

outcome measure : time of no flow during Resuscitation by trained paramedical staff in out of hospital cardiac arrest

arrival of paramedical staff T0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
No flow proportion during resuscitation by paramedical staff after emergency training
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
no flow proportion on total resuscitation duration
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
number of failure installation after 2 tests
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
Time of device installation
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
chest expansion during insuflation (yes/no)
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
Mortality : spontaneous cardiac activity recovery, hospital admission, reanimation service or hospital exit date, survival at 28 days , CPC evaluation for patients alive
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0

incident during ventilation :

obstruction number of manipulations to optimize ventilation

during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
ETCO2
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest at T0
Number of external electric shocks
during cardiac arrest at T0
qualitative observation of laryngeal tube use for ventilation of patients in cardiac arrest
Time Frame: during cardiac arrest a T0
degradation due to technical manipulations
during cardiac arrest a T0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vincent Danel, MD, University Hospital, Grenoble

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

February 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

February 11, 2011

First Submitted That Met QC Criteria

February 11, 2011

First Posted (Estimate)

February 14, 2011

Study Record Updates

Last Update Posted (Estimate)

July 3, 2012

Last Update Submitted That Met QC Criteria

July 2, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on laryngeal tube ventilation and continuous chest compression

3
Subscribe